Clinical Trial Update: Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy plus rituximab for adults with Burkitt lymphoma or B-cell acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Burkitt Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Northern Italy Leukemia Group | Conditions: Burkitt Lymphoma, B-ALL | Phase 2 | Status: COMPLETED